SEC Comment Letter 0000000000-23-012051 to iBio, Inc. (IBIO)

iBio, Inc.
Date: Nov. 3, 2023 · CIK: 0001420720 · Accession: 0000000000-23-012051

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-275204

Date

November 3, 2023

Author

Marc Banjak

Form

UPLOAD

Company

iBio, Inc.

Letter

United States securities and exchange commission logo November 3, 2023 Marc Banjak General Counsel iBio, Inc. 8800 HSC Parkway Bryan, Texas 77807 Re:iBio, Inc. Registration Statement on Form S-3 Filed October 27, 2023 File No. 333-275204 Dear Marc Banjak: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Leslie Marlow

Show Raw Text

United States securities and exchange commission logo
November 3, 2023
Marc Banjak
General Counsel
iBio, Inc.
8800 HSC Parkway
Bryan, Texas 77807
Re:iBio, Inc.
Registration Statement on Form S-3
Filed October 27, 2023
File No. 333-275204
Dear Marc Banjak:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Leslie Marlow

SecProbe.io